Search Results - "Lindenmayer, J.P."

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Pomaglumetad methionil: No significant difference as an adjunctive treatment for patients with prominent negative symptoms of schizophrenia compared to placebo by Stauffer, Virginia L, Millen, Brian A, Andersen, Scott, Kinon, Bruce J, LaGrandeur, Lisa, Lindenmayer, J.P, Gomez, Juan Carlos

    Published in Schizophrenia research (01-11-2013)
    “…Abstract This study tested whether treatment with pomaglumetad methionil (LY2140023 monohydrate), a metabotropic glutamate receptor 2/3 agonist compared with…”
    Get full text
    Journal Article
  2. 2

    Transcranial direct-current stimulation in ultra-treatment-resistant schizophrenia by Lindenmayer, J.P., Kulsa, Mila Kirstie C., Sultana, Tania, Kaur, Amandeep, Yang, Ran, Ljuri, Isidora, Parker, Benedicto, Khan, Anzalee

    Published in Brain stimulation (01-01-2019)
    “…Transcranial direct-current stimulation (tDCS), a non-invasive neurostimulation treatment, has been reported in a number of sham-controlled studies to show…”
    Get full text
    Journal Article
  3. 3

    The relationship of cognitive improvement after cognitive remediation with social functioning in patients with schizophrenia and severe cognitive deficits by Lindenmayer, J.P, Fregenti, Samantha, Kang, Guoxin, Ozog, Veronica, Ljuri, Isidora, Khan, Anzalee, Goldring, A, McGurk, Susan R

    Published in Schizophrenia research (01-07-2017)
    “…Abstract Background This study aims to examine the effects of change in neurocognition on functional outcomes and to examine predictors of change in social…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Schizophrenia with Impulsive and Aggressive Behaviors by Lindenmayer, J.P., MD, Kanellopoulou, Isabella, MD

    Published in The Psychiatric clinics of North America (01-12-2009)
    “…Impulsive and aggressive behaviors are important clinical challenges in the treatment of patients with schizophrenia. They occur both in the acute phase as…”
    Get full text
    Journal Article
  6. 6

    Schizophrenia: Measurements of Psychopathology by Lindenmayer, J.P., MD, Harvey, Philip D., PhD, Khan, Anzalee, MS, Kirkpatrick, Brian, MD

    Published in The Psychiatric clinics of North America (01-09-2007)
    “…A key problem in schizophrenia research is how to assess the effects of treatment interventions given the spectrum of schizophrenia symptoms and patients'…”
    Get full text
    Journal Article
  7. 7

    Transcultural differences in suicide attempters: Analysis on a high-risk population of patients with schizophrenia or schizoaffective disorder by Altamura, A.C, Mundo, E, Bassetti, R, Green, A, Lindenmayer, J.P, Alphs, L, Meltzer, H.Y

    Published in Schizophrenia research (01-01-2007)
    “…Abstract The aim of the study was to investigate transcultural differences between schizophrenia spectrum disorder patients who did or did not attempt suicide…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    N-desmethylclozapine: is there evidence for its antipsychotic potential? by Mendoza, Maria Cristina, Lindenmayer, J P

    Published in Clinical neuropharmacology (01-05-2009)
    “…N-Desmethylclozapine (NDMC), one of clozapine's major metabolites, has become a recent focus of study for both its antipsychotic and metabolic effects. The aim…”
    Get full text
    Journal Article
  11. 11

    The InterSePT scale for suicidal thinking reliability and validity by Lindenmayer, J.P, Czobor, Pal, Alphs, Larry, Nathan, Ann-Marie, Anand, Ravi, Islam, Zahur, Chou, James C.Y

    Published in Schizophrenia research (01-09-2003)
    “…Background: The InterSePT Scale for Suicidal Thinking (ISST) is a 12-item instrument for the assessment of current suicidal ideation in patients with…”
    Get full text
    Journal Article
  12. 12

    Pharmacological treatment strategies for schizophrenia by Lindenmayer, J P, Khan, Anzalee

    Published in Expert review of neurotherapeutics (01-07-2004)
    “…The pharmacological choices for the treatment of schizophrenia have been greatly expanded with the availability of the atypical compounds clozapine (Clozaril,…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15